Psychiatry for Practice, 2006, issue 4

Ambulantní psychiatři - zápis ze schůze

MUDr. Erik Herman

Psychiatr. pro Praxi, 2006; 4: 196  

Review articles

Long-term treatment of schizophrenia

MUDr. Klára Látalová, doc. MUDr. Vladimír Pidrman Ph.D

Psychiatr. pro Praxi, 2006; 4: 158-160  

Schizophrenia is a serious psychotic disease with a prolonged course, significant functional affection and reduced quality of life in its characteristics. Disease has a serious impact on patients families and whole society. The aim of long-term treatment is maintenance of improvement which was acquired during acute or stabilizing treatment, prevention of relapse, elimination of negative signs and formation conditions for return to a full social competence.

Current trends in the treatment of bipolar affective disorder

MUDr. Homayun Shahpesandy, MUDr. Zuzana Janíková, MUDr. Jaroslava Pristášová, MUDr. Ružena Mojžišová, Mgr. Oľga Šupalová, Mgr. Viera Kasanická

Psychiatr. pro Praxi, 2006; 4: 161-164  

Bipolar affective disorders is a complex disorder for which treatment includes a high number of psychotropic medications, such as mood stabilizers, antidepressants, anxiolytics, hypnotics and, of course antipsychotics. The rational combination of some of these drugs, the right dose, duration of treatment, and individualized treatment, together with psychoeducation constitute the ideal form of treament of patients suffering from this disorder. This paper presents the recent trends in the treatment of bipolar affective disorder, focuses on advantages and side effects of the availabe medications and on the treatment of this disorder during the pregnancy...

Depression, coronary artery disease, and myocardial infarction

MUDr. Jiří Podlipný

Psychiatr. pro Praxi, 2006; 4: 165-167  

There is a strong relationship between coronary artery disease (CAD) and depression. Patients after myocardial infarction often suffer from depressive disorder and this comorbidity can be explained by some common pathophysiological mechanisms. The selective serotonin reuptake inhibitors are the most feasible pharmacologic treatment of depression after myocardial infarction. It is also important to keep in mind the influence of CAD pharmaceuticals on the human psyche.

Clinical benefit of pharmacogenetics in psychiatry

doc. MUDr. Ladislav Hosák Ph.D

Psychiatr. pro Praxi, 2006; 4: 168-170  

Pharmacogenetics deals with genetic aspects of pharmacotherapy especially related to therapeutic and adverse drug effects with a potential of their individual prediction. The number of published pharmacogenetic papers in psychiatry grows. In schizophrenia, nearly all studies published in the last century were concerned with clozapine, more recent publications also mention olanzapine, quetiapine, risperidone, ziprasidone and other preparations. Research into the 5-HT2A receptor gene looks promising with regard to prediction of treatment response to second generation antipsychotics. The results of studies on the 5-HTTLPR polymorphism of the gene for...

Diagnostic and treatment of depressive episode of bipolar affective disorder

MUDr. Erik Herman, MUDr. Pavel Doubek, doc. MUDr. Ján Praško CSc, doc. MUDr. Jiří Hovorka CSc

Psychiatr. pro Praxi, 2006; 4: 171-172  

Bipolar affective disorder, which is not properly diagnosed and treated, has significant negative influence to the life of the patient. Highly important is to differentiate bipolar disorder from the periodic depressive disorder. The goal of the treatment is not only the treatment of single episodes, but the prophylaxis of next episodes. Prescribing of mood stabilisers is essential in the treatment of all phases of illness.

Antidepressives and hypnotics of the 3rd generation in the treatment of chronic insomnia

MUDr. Lucie Závěšická

Psychiatr. pro Praxi, 2006; 4: 174-175  

According available literature, the incidence of chronic insomnia is around 10 %. The treatment of chronic insomnia consists most frequently of cognitive-behavioral psychotherapy, hypnotics and antidepressives. Recently we have a lot of information from clinical studies that are testing the effectiveness of therapy of antidepressives and hypnotics of the 3rd generation in the indication of chronic insomnia.

Case report

Případ indukované sebevraždy

MUDr. Richard Krombholz, MUDr. Hana Drástová

Psychiatr. pro Praxi, 2006; 4: 177-178  

Depresivní syndrom u seniorů, významný a dosud nedoceněný problém

MUDr. Iva Holmerová Ph.D, MUDr. Hana Vaňková, MUDr. Eva Dragomirecká, PhDr. Hana Janečková Ph.D, MUDr. Petr Veleta

Psychiatr. pro Praxi, 2006; 4: 182-184  

Ťažké delírium tremens komplikované rabdomyolýzou s akútnym renálnym zlyhaním

MUDr. Jozef Kalužay, MUDr. Katarína Sigmundová, MUDr. Petra Nosá\'lová, MUDr. Patrik Podaný

Psychiatr. pro Praxi, 2006; 4: 179-181  

At a glance

Zvládanie akútneho psychomotorického nekľudu a agresivity pacienta

MUDr. Marek Zelman, MUDr. Karol Hollý, Mgr. Helena Bračoková

Psychiatr. pro Praxi, 2006; 4: 185-190  

Péče o suicidálního pacienta

doc. MUDr. Ján Praško CSc

Psychiatr. pro Praxi, 2006; 4: 191-195  

Information and commentaries

ze zahraniční literatury

MUDr. Tomáš Kašpárek Ph.D

Psychiatr. pro Praxi, 2006; 4: 197  

Počátky moravské psychiatrie III.

MUDr. Emanuel Doněk, MUDr. Jana Doňková

Psychiatr. pro Praxi, 2006; 4: 198  


Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.